PAVmed, Inc. (PAVM)
2.79
+0.10
(+3.72%)
USD |
NASDAQ |
Oct 09, 16:00
2.79
0.00 (0.00%)
After-Hours: 20:00
PAVmed Free Cash Flow : -7.782M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.782M |
| March 31, 2026 | -6.292M |
| December 31, 2025 | -5.237M |
| September 30, 2025 | -3.582M |
| June 30, 2025 | -11.57M |
| March 31, 2025 | -22.04M |
| December 31, 2024 | -33.61M |
| September 30, 2024 | -45.76M |
| June 30, 2024 | -47.97M |
| March 31, 2024 | -49.12M |
| December 31, 2023 | -52.28M |
| September 30, 2023 | -57.34M |
| June 30, 2023 | -65.89M |
| March 31, 2023 | -76.00M |
| December 31, 2022 | -72.52M |
| September 30, 2022 | -73.46M |
| June 30, 2022 | -61.85M |
| March 31, 2022 | -45.69M |
| December 31, 2021 | -42.06M |
| September 30, 2021 | -30.74M |
| June 30, 2021 | -28.53M |
| March 31, 2021 | -27.38M |
| Date | Value |
|---|---|
| December 31, 2020 | -21.97M |
| September 30, 2020 | -19.33M |
| June 30, 2020 | -16.36M |
| March 31, 2020 | -13.30M |
| December 31, 2019 | -13.38M |
| September 30, 2019 | -12.31M |
| June 30, 2019 | -11.33M |
| March 31, 2019 | -10.49M |
| December 31, 2018 | -8.814M |
| September 30, 2018 | -7.379M |
| June 30, 2018 | -7.862M |
| March 31, 2018 | -6.983M |
| December 31, 2017 | -6.614M |
| September 30, 2017 | -6.229M |
| June 30, 2017 | -5.091M |
| March 31, 2017 | -5.776M |
| December 31, 2016 | -4.477M |
| September 30, 2016 | -3.922M |
| June 30, 2016 | -3.005M |
| March 31, 2016 | -1.723M |
| December 31, 2015 | -1.250M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.824B |
| AngioDynamics, Inc. | -3.873M |
| Alphatec Holdings, Inc. | -5.739M |
| AtriCure, Inc. | 53.11M |
| Baxter International, Inc. | 812.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.663M |
| Cash from Investing (Quarterly) | -0.013M |
| Free Cash Flow Per Share (Quarterly) | -0.4268 |
| Free Cash Flow to Equity (Quarterly) | -2.734M |
| Free Cash Flow to Firm (Quarterly) | -2.674M |
| Free Cash Flow Yield | -119.4% |